INS and type 2 diabetes mellitus: Moreover, in rats with type 2 diabetes, chronic oral administration of butanol fraction for 28 days significantly decreased blood glucose, increased plasma insulin, pancreatic insulin stored, liver glycogen, and improved lipid profile [36].